Avitar, Inc. (AVTI)

OTCMKTS · Delayed Price · Currency is USD

0.0000

0.00 (0.00%)

Mar 5, 2026, 4:00 PM EST

900.00% (1Y)

Market Cap	731.00
Revenue (ttm)	2.66M
Net Income (ttm)	-2.80M
Shares Out	731.31M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	663,441
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.0000 - 0.0000
Beta	-72.57
RSI	47.38
Earnings Date	n/a

About Avitar

Avitar, Inc., through its subsidiaries, designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine, such as crack; marijuana;... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1986

Employees 36

Stock Exchange OTCMKTS

Ticker Symbol AVTI

Full Company Profile

Financial Performance

In fiscal year 2007, Avitar's revenue was $3.11 million, a decrease of -31.26% compared to the previous year's $4.52 million. Losses were -$2.41 million, -37.61% less than in 2006.

Financial Statements

News

There is no news available yet.